Boehringer Ingelheim's TwistPak® mixing platform for swine vaccines brings convenience and flexibility
TwistPak® allows for fresh mixing of Ingelvac CircoFLEX® and Ingelvac MycoFLEX® on farm in less than 5 seconds.
articles about mycoplasma in Press releases
University of Minnesota swine professors receive awards at CVM Research Day
Dr. Maria Pieters and Dr. Noelle Noyes receive awards at the Points of Pride Research Day of the UMN College of Veterinary Medicine.
Ceva receives positive opinion from EMA for Circovac® + Hyogen® Ready to Mix: DUO™ swine vaccines
The combination of products gives protection against PCV2 and Mycoplasma hyopneumoniae until 26 weeks of age.
Zoetis launches CircoMax® Myco to deliver broader coverage against PCV2
Unique PCV2 and M. hyopneumoniae ready-to-use, single-dose combination vaccine on the market.
Pharmgate: Aivlosin® WSG approved in U.S. and Canada to control Mycoplasma hyopneumoniae
This approval gives Aivlosin® WSG the broadest label indication of any product for the control of swine respiratory disease (SRD).
Zoetis Receives European Commission Marketing Authorization for CircoMax® Myco
First PCV2 and M. hyopneumoniae combination vaccine in the EU for pigs that includes two PCV2 genotypes for broader coverage against continuously evolving Porcine Circovirus.
New Swine Claim for Lincomix® Provides Flexible Dosing for M. hyo
Now Lincomix® can be administered at 100 to 200 grams per ton of feed for 21 days to reduce the severity of respiratory disease associated with M. hyo.
Ceva enters European swine vaccine market with new, targeted vaccine to improve control of enzootic pneumonia
Experts meet in Barcelona to discuss new strategies to prevent the disease.
Controlling disease in young pigs
Mycoplasmal pneumonia and porcine circovirus are two of the costliest diseases affecting pork producers. Helping provide protection before disease exposure is critical to the success of any vaccination program.
RespiSure-ONE® now registered for use in day old piglets
Canadian swine producers can now vaccinate for mycoplasma pneumonia when they process baby pigs. A new label claim makes RespiSure-ONE the only vaccine approved for administration at one day of age.
USGC consultant boosts Mycotoxin understanding in Taiwan
A Kansas State microbiology expert has completed an intense schedule of briefings in Taiwan in an outreach effort to update industry and government officials on mycotoxins.
New Fostera PCV is the only single-dose vaccine that helps prevent PCV2 viremia
Veterinarians and pork producers can now help prevent Porcine Circovirus Type 2 (PCV2) viremia with the convenience of a single dose. New Fostera™ PCV from Pfizer Animal Health is the result of the company's commitment to best practices and continuous quality improvements.
Day one Mycoplasma hyopneumoniae vaccination now possible with RespiSure-ONE®
Pork producers in US can now vaccinate for mycoplasmal pneumonia at day one.
Intervet/Schering-Plough animal health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swine
Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.
First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union
The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.
Intervet/Schering-Plough Animal Health receives positive opinion in europe for simultaneous use of Porcilis® PRRS and Porcilis® M hyo vaccines in piglets
Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) concluded the referral procedure for PORCILIS® PRRS and for PORCILIS® M Hyo on simultaneous administration of these products in piglets